Variant report
Variant | nsv610216 |
---|---|
Chromosome Location | chr8:9055740-9061631 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:16)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:16 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RP11-10A14.4.1-2 | chr8:9060009-9060347 | ENSG00000248538 |
2 | lnc-RP11-10A14.4.1-2 | chr8:9056434-9056501 | ENSG00000248538 |
3 | lnc-RP11-10A14.4.1-2 | chr8:9059902-9060000 | ENSG00000248538 |
4 | lnc-RP11-10A14.4.1-2 | chr8:9059902-9060357 | NONHSAT124931 |
5 | lnc-RP11-10A14.4.1-2 | chr8:9056434-9056501 | NONHSAT124925 |
6 | lnc-RP11-10A14.4.1-2 | chr8:9060009-9060366 | XLOC_006705 |
7 | lnc-RP11-10A14.4.1-2 | chr8:9056434-9056501 | XLOC_006705 |
8 | lnc-RP11-10A14.4.1-2 | chr8:9060009-9060364 | ENSG00000248538 |
9 | lnc-RP11-10A14.4.1-2 | chr8:9056378-9056501 | NONHSAT124931 |
10 | lnc-RP11-10A14.4.1-2 | chr8:9060009-9060368 | NONHSAT124925 |
11 | lnc-RP11-10A14.4.1-2 | chr8:9060009-9060363 | XLOC_006705 |
12 | lnc-RP11-10A14.4.1-2 | chr8:9056378-9056501 | NONHSAT124930 |
13 | lnc-RP11-10A14.4.1-2 | chr8:9056434-9056501 | ENSG00000248538 |
14 | lnc-RP11-10A14.4.1-2 | chr8:9060009-9060357 | NONHSAT124930 |
15 | lnc-RP11-10A14.4.1-2 | chr8:9056434-9056501 | ENSG00000248538 |
16 | lnc-RP11-10A14.4.1-2 | chr8:9056434-9056501 | XLOC_006705 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7842096 | chr8:9055740-9055741 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs545553557 | chr8:9055745-9055746 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562482836 | chr8:9055748-9055749 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575910585 | chr8:9055758-9055759 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10094141 | chr8:9055772-9055773 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs561142782 | chr8:9055776-9055777 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs76144947 | chr8:9055797-9055798 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs79063551 | chr8:9055803-9055804 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183951886 | chr8:9055813-9055814 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560532749 | chr8:9055820-9055821 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375018863 | chr8:9055823-9055824 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532796911 | chr8:9055826-9055827 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs138833053 | chr8:9055843-9055844 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187233946 | chr8:9055873-9055874 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs112952036 | chr8:9055875-9055876 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141351371 | chr8:9055926-9055927 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191161464 | chr8:9055939-9055940 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs369195053 | chr8:9055958-9055959 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574431217 | chr8:9055988-9055989 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182950532 | chr8:9056011-9056012 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533733917 | chr8:9056019-9056020 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs545563999 | chr8:9056022-9056023 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553594341 | chr8:9056050-9056051 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570202438 | chr8:9056068-9056069 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs187668045 | chr8:9056099-9056100 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191745228 | chr8:9056105-9056106 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs370762603 | chr8:9056127-9056128 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2242282 | chr8:9056136-9056137 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs2242281 | chr8:9056151-9056152 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs574752575 | chr8:9056182-9056183 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs149372757 | chr8:9056222-9056223 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs61738069 | chr8:9056240-9056241 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs144713359 | chr8:9056275-9056276 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546451884 | chr8:9056313-9056314 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183038934 | chr8:9056314-9056315 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562064771 | chr8:9056323-9056324 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576616855 | chr8:9056331-9056332 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs1842582 | chr8:9056337-9056338 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs568695816 | chr8:9056357-9056358 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187690529 | chr8:9056363-9056364 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs61744440 | chr8:9056409-9056410 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs570247289 | chr8:9056422-9056423 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs2242280 | chr8:9056426-9056427 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs555813532 | chr8:9056454-9056455 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs141961550 | chr8:9056461-9056462 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs142715451 | chr8:9056466-9056467 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs192404691 | chr8:9056494-9056495 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs532676483 | chr8:9056512-9056513 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs138406291 | chr8:9056522-9056523 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs540300465 | chr8:9056526-9056527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Developmental disorder | 20461109 | CNVD |
abnormal development | 18461090 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:9049400-9056200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
2 | chr8:9049800-9055800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr8:9052400-9056600 | Weak transcription | Placenta | Placenta |
4 | chr8:9055000-9056400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr8:9055000-9056400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr8:9055000-9056400 | Enhancers | Fetal Heart | heart |
7 | chr8:9055200-9055800 | Flanking Active TSS | K562 | blood |
8 | chr8:9055200-9056000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
9 | chr8:9055200-9056200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
10 | chr8:9055400-9056600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr8:9055400-9057000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr8:9055400-9057000 | Enhancers | Ovary | ovary |
13 | chr8:9055800-9056200 | Enhancers | K562 | blood |
14 | chr8:9055800-9056600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr8:9056200-9056400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr8:9056200-9056600 | Enhancers | H9 Cell Line | embryonic stem cell |
17 | chr8:9056200-9057000 | Enhancers | H1 Cell Line | embryonic stem cell |
18 | chr8:9056200-9057000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
19 | chr8:9056600-9058400 | Strong transcription | Placenta | Placenta |
20 | chr8:9056600-9064000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
21 | chr8:9058400-9063000 | Weak transcription | Placenta | Placenta |
22 | chr8:9059600-9060000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
23 | chr8:9059800-9061400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |